This is a study in Japanese healthy volunteers to determine the safety and tolerability of the compound AZD7687. It will also assess how the body handles the drug and how it responds to the drug following single dose followed by multiple dosing over 7 days.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Enrollment
36
Oral suspension
Research site
Croydon, United Kingdom
Investigate the safety and tolerability of AZD7687 following administration of single and multiple doses
Time frame: From screening period to follow-up visit 45 days (Maximum).
Evaluate the pharmacokinetics (PK) (plasma and urine) of AZD7687 and it´s glucuronic acid metabolite (AZ13128940) after single and multiple doses
Time frame: Before dose and repeatedly to follow-up visit
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.